Sectors
USNA
USANA Health Sciences, Inc.
14.26
400 x 14.03
500 x 14.71
bid
ask
+
0.22
1.57%
450 @ 07:30 PM
14.26 +0.00 (0.00%)
| Ytd | -27.36% | |
| 1y | -55.31% |
13.47
day range
14.57
12.57
52 week range
32.29
| Open | 13.98 | Prev Close | 14.04 | Low | 13.47 | High | 14.57 | Mkt Cap | 263.48M |
| Vol | 333.39K | Avg Vol | 152.40K | EPS | -1.18 | P/E | N/A | Forward P/E | 13.69 |
| Beta | 0.89 | Short Ratio | 5.95 | Inst. Own | 57.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-21 | 50-d Avg | 18.77 | 200-d Avg | 19.23 | 1yr Est | 46.50 |
| Income Statement | |||
| Total Revenue | 223.27M | ||
| Revenues (USD) | 223.27M | ||
| Cost of Revenue | 48.34M | ||
| Gross Profit | 174.93M | ||
| Operating Expenses | 194.93M | ||
| Selling, General and Administrative Expense | 165.79M | ||
| Operating Income | -20.00M | ||
| Income Tax Expense | 9.05M | ||
| Net Income | -21.38M | ||
| Net Income Common Stock | -21.38M | ||
| Net Income Common Stock (USD) | -21.38M | ||
| Consolidated Income | -27.95M | ||
| Net Income to Non-Controlling Interests | -6.57M | ||
| Earnings per Basic Share | -1.16 | ||
| Earnings per Basic Share (USD) | -1.16 | ||
| Earnings per Diluted Share | -1.16 | ||
| Earning Before Interest & Taxes (EBIT) | -12.33M | ||
| Earning Before Interest & Taxes (USD) | -12.33M | ||
| Weighted Average Shares | 18.49M | ||
| Weighted Average Shares Diluted | 18.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 168.56M | ||
| Cash and Equivalents (USD) | 168.56M | ||
| Trade and Non-Trade Receivables | 3.34M | ||
| Current Assets | 281.07M | ||
| Property, Plant & Equipment Net | 94.27M | ||
| Total Assets | 703.21M | ||
| Current Liabilities | 105.68M | ||
| Total Liabilities | 132.24M | ||
| Accumulated Retained Earnings (Deficit) | 451.85M | ||
| Accumulated Other Comprehensive Income | -13.68M | ||
| Shareholders Equity | 526.31M | ||
| Shareholders Equity (USD) | 526.31M | ||
| Assets Non-Current | 422.14M | ||
| Goodwill and Intangible Assets | 233.76M | ||
| Inventory | 86.34M | ||
| Liabilities Non-Current | 26.56M | ||
| Trade and Non-Trade Payables | 15.43M | ||
| Tax Assets | 29.54M | ||
| Tax Liabilities | 4.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.17M | ||
| Net Cash Flow from Financing | -14.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.85M | ||
| Capital Expenditure | -3.14M | ||
| Issuance (Repayment) of Debt Securities | -14.00M | ||
| Net Cash Flow from Investing | -4.06M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -917.00K | ||
| Net Cash Flow from Operations | 23.32M | ||
| Effect of Exchange Rate Changes on Cash | 615.00K | ||
| Share Based Compensation | 3.40M | ||